Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study

Authors:

Abstract
No abstract available
Funding Information
  • National Cancer Research Institute

This publication has 44 references indexed in Scilit: